(Q32077087)

English

Imaging brain cholinergic activity with positron emission tomography: its role in the evaluation of cholinergic treatments in Alzheimer's dementia

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 July 2017

1 reference

Europe PubMed Central

Imaging brain cholinergic activity with positron emission tomography: its role in the evaluation of cholinergic treatments in Alzheimer's dementia (English)

1 reference

Europe PubMed Central

6 July 2017

Alzheimer's disease

0 references

1 reference

based on heuristic

inferred from title

positron emission tomography

1 reference

based on heuristic

inferred from title

author name string

Volkow ND

1

1 reference

Europe PubMed Central

6 July 2017

Ding YS

2

1 reference

Europe PubMed Central

6 July 2017

Fowler JS

3

1 reference

Europe PubMed Central

6 July 2017

Gatley SJ

4

1 reference

Europe PubMed Central

6 July 2017

language of work or name

0 references

publication date

1 February 2001

1 reference

Europe PubMed Central

6 July 2017

Biological Psychiatry

1 reference

Europe PubMed Central

6 July 2017

49

1 reference

Europe PubMed Central

6 July 2017

3

1 reference

Europe PubMed Central

6 July 2017

211-220

1 reference

Europe PubMed Central

6 July 2017

Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Potential for imaging cerebral amyloid deposits using 123I-labelled serum amyloid P component and SPET.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Synthesis and evaluation of 6-[11C]methoxy-3-[2-[1-(phenylmethyl)-4-piperidinyl]ethyl]-1,2- benzisoxazole as an in vivo radioligand for acetylcholinesterase.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Xanomeline compared to other muscarinic agents on stimulation of phosphoinositide hydrolysis in vivo and other cholinomimetic effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Muscarinic cholinergic receptor measurements with [18F]FP-TZTP: control and competition studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

2-[18F]F-A-85380: a PET radioligand for alpha4beta2 nicotinic acetylcholine receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

A comparison of the binding of nicotine and nornicotine stereoisomers to nicotinic binding sites in rat brain cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Striatal binding of the PET ligand 11C-raclopride is altered by drugs that modify synaptic dopamine levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Age-related decreases in muscarinic cholinergic receptor binding in the human brain measured with positron emission tomography (PET).

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Mapping nicotinic acetylcholine receptors with PET.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Synthesis and evaluation of 6-[18F]fluoro-3-(2(S)-azetidinylmethoxy)pyridine as a PET tracer for nicotinic acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Comparative studies of epibatidine derivatives [18F]NFEP and [18F]N-methyl-NFEP: kinetics, nicotine effect, and toxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Occupancy of brain nicotinic acetylcholine receptors by nicotine doses equivalent to those obtained when smoking a cigarette

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

External imaging of cerebral muscarinic acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

18F-2-deoxy-2-fluoro-D-glucose as a tracer in the positron emission tomographic study of senile dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Cholinergic stimulation alters performance and task-specific regional cerebral blood flow during working memory

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Effect of central cholinergic stimulation on regional cerebral blood flow in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Intravenous physostigmine treatment of Alzheimer's disease evaluated by psychometric testing, regional cerebral blood flow (rCBF) measurement, and EEG.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

(S)- and (R)-[11C]nicotine and the metabolite (R/S)-[11C]cotinine. Preparation, metabolite studies and in vivo distribution in the human brain using PET

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Impairment of neocortical metabolism predicts progression in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Pharmacological evaluation of [11C]A-84543: an enantioselective ligand for in vivo studies of neuronal nicotinic acetylcholine receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Microdialysis and SPECT measurements of amphetamine-induced dopamine release in nonhuman primates.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Nicotine enhances the biosynthesis and secretion of transthyretin from the choroid plexus in rats: implications for beta-amyloid formation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Imaging of cholinergic terminals using the radiotracer [18F](+)-4-fluorobenzyltrozamicol: in vitro binding studies and positron emission tomography studies in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Reduced antinociception in mice lacking neuronal nicotinic receptor subunits

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Overlap between acetylcholinesterase-rich and choline acetyltransferase-positive (cholinergic) axons in human cerebral cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Nicotine, brain nicotinic receptors, and neuropsychiatric disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Fluoro-norchloroepibatidine: preclinical assessment of acute toxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

[18F]fluoroethoxy-benzovesamicol, a PET radiotracer for the vesicular acetylcholine transporter and cholinergic synapses.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Long-term tacrine treatment in three mild Alzheimer patients: effects on nicotinic receptors, cerebral blood flow, glucose metabolism, EEG, and cognitive abilities.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Uptake and regional distribution of (+)-(R)- and (-)-(S)-N-[methyl-11C]-nicotine in the brains of rhesus monkey. An attempt to study nicotinic receptors in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Tacrine restores cholinergic nicotinic receptors and glucose metabolism in Alzheimer patients as visualized by positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Imaging of nicotinic and muscarinic receptors in Alzheimer's disease: effect of tacrine treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Reduced number of [3H]nicotine and [3H]acetylcholine binding sites in the frontal cortex of Alzheimer brains.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

In vivo imaging of human cerebral acetylcholinesterase.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

The role of emission tomography in dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Rat brain acetylcholinesterase visualized with [11C]physostigmine.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

In vivo fatty acid incorporation into brain phospholipids in relation to signal transduction and membrane remodeling

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

In vivo positron emission tomography studies on the novel nicotinic receptor agonist [11C]MPA compared with [11C]ABT-418 and (S)(-)[11C]nicotine in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Changes in the rCBF images of patients with Alzheimer's disease receiving Donepezil therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

[Cerebral glucose metabolism in presenile dementia of the Alzheimer type--follow-up of therapy with muscarinergic choline agonists]

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

In vivo PET study of cerebral [11C] methyl- tetrahydroaminoacridine distribution and kinetics in healthy human subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

The acetylcholine releaser linopirdine increases parietal regional cerebral blood flow in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Imaging endogenous dopamine competition with [11C]raclopride in the human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Visual form of Alzheimer's disease and its response to anticholinesterase therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Visualization of the vesicular acetylcholine transporter in cholinergic nerve terminals and its targeting to a specific population of small synaptic vesicles

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

The distribution of cerebral muscarinic acetylcholine receptors in vivo in patients with dementia. A controlled study with 123IQNB and single photon emission computed tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Deficits in iodine-labelled 3-quinuclidinyl benzilate binding in relation to cerebral blood flow in patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Synthesis and amyloid binding properties of rhenium complexes: preliminary progress toward a reagent for SPECT imaging of Alzheimer's disease brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Quantification of muscarinic cholinergic receptors with [11C]NMPB and positron emission tomography: method development and differentiation of tracer delivery from receptor binding.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Tacrine interacts with an allosteric activator site on alpha 4 beta 2 nAChRs in M10 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Kinetic analysis of regional (S)(-)11C-nicotine binding in normal and Alzheimer brains--in vivo assessment using positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0006-3223(00)01112-4

1 reference

Europe PubMed Central

6 July 2017

1 reference

Europe PubMed Central

6 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q32077087&oldid=2041999939"